StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.66−0.16 (-8.79%)

Close on Nov 20, 2026Market cap $52.92MP/E –Yield –

Longeveron market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Longeveron's market cap was $53.73B on Nov 11, 2026, against $80.09B a year earlier. Over the last 5 years it ranged from $113.02M to $529.43B, with a median of $54.74B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$53.73B-12.0%
2025Dec 31, 2025$61.06B-43.6%
2024Dec 31, 2024$108.18B+37835.0%
2023Dec 29, 2023$285.18M-56.3%
2022Dec 30, 2022$652.06M-99.9%
2021Dec 31, 2021$529.43B–

More Longeveron figures

See a number that looks wrong?